93 related articles for article (PubMed ID: 8887456)
1. Difference between normal and WHHL rabbits in susceptibility to the adrenal toxicity of an acyl-CoA:cholesterol acyltransferase inhibitor, FR145237.
Matsuo M; Hashimoto M; Suzuki J; Iwanami K; Tomoi M; Shimomura K
Toxicol Appl Pharmacol; 1996 Oct; 140(2):387-92. PubMed ID: 8887456
[TBL] [Abstract][Full Text] [Related]
2. Effect of FR145237, a novel ACAT inhibitor, on atherogenesis in cholesterol-fed and WHHL rabbits. Evidence for a direct effect on the arterial wall.
Matsuo M; Ito F; Konto A; Aketa M; Tomoi M; Shimomura K
Biochim Biophys Acta; 1995 Dec; 1259(3):254-60. PubMed ID: 8541332
[TBL] [Abstract][Full Text] [Related]
3. Effect of fluvastatin sodium on the smooth muscle cells in atherosclerotic plaques. In vivo study using low-density lipoprotein receptor deficient Watanabe heritable hyperlipidemic (WHHL) rabbits.
Shiomi M; Ito T; Tsukada T; Shiraishi M; Yata T
Arzneimittelforschung; 1998 Jun; 48(6):680-5. PubMed ID: 9689427
[TBL] [Abstract][Full Text] [Related]
4. Enhanced aortic atherosclerosis in transgenic Watanabe heritable hyperlipidemic rabbits expressing lipoprotein lipase.
Koike T; Liang J; Wang X; Ichikawa T; Shiomi M; Sun H; Watanabe T; Liu G; Fan J
Cardiovasc Res; 2005 Feb; 65(2):524-34. PubMed ID: 15639492
[TBL] [Abstract][Full Text] [Related]
5. Pharmacological profile of SMP-797, a novel acyl-coenzyme a: cholesterol acyltransferase inhibitor with inducible effect on the expression of low-density lipoprotein receptor.
Ioriya K; Kino K; Horisawa S; Nishimura T; Muraoka M; Noguchi T; Ohashi N
J Cardiovasc Pharmacol; 2006 Feb; 47(2):322-9. PubMed ID: 16495773
[TBL] [Abstract][Full Text] [Related]
6. Anti-atherosclerotic effect of E5324, an inhibitor of acyl-CoA:cholesterol acyltransferase, in Watanabe heritable hyperlipidemic rabbits.
Kogushi M; Tanaka H; Ohtsuka I; Yamada T; Kobayashi H; Saeki T; Takada M; Hiyoshi H; Yanagimachi M; Kimura T; Yoshitake S; Saito I
Atherosclerosis; 1996 Aug; 124(2):203-10. PubMed ID: 8830933
[TBL] [Abstract][Full Text] [Related]
7. Pactimibe stabilizes atherosclerotic plaque through macrophage acyl-CoA:cholesterol acyltransferase inhibition in WHHL rabbits.
Kitayama K; Koga T; Maeda N; Inaba T; Fujioka T
Eur J Pharmacol; 2006 Jun; 539(1-2):81-8. PubMed ID: 16690054
[TBL] [Abstract][Full Text] [Related]
8. ACAT-selective and nonselective DGAT1 inhibition: adrenocortical effects--a cross-species comparison.
Floettmann JE; Buckett LK; Turnbull AV; Smith T; Hallberg C; Birch A; Lees D; Jones HB
Toxicol Pathol; 2013; 41(7):941-50. PubMed ID: 23427273
[TBL] [Abstract][Full Text] [Related]
9. Morphogenesis of a zone-specific adrenocortical cytotoxicity in guinea pigs administered PD 132301-2, an inhibitor of acyl-CoA:cholesterol acyltransferase.
Dominick MA; Bobrowski WA; MacDonald JR; Gough AW
Toxicol Pathol; 1993; 21(1):54-62. PubMed ID: 8397438
[TBL] [Abstract][Full Text] [Related]
10. Statin therapy alone and in combination with an acyl-CoA:cholesterol O-acyltransferase inhibitor on experimental atherosclerosis.
Worthley SG; Helft G; Corti R; Worthley MI; Chew DP; Fayad ZA; Zaman AG; Fallon JT; Fuster V; Badimon JJ
Pathophysiol Haemost Thromb; 2007; 36(1):9-17. PubMed ID: 18332609
[TBL] [Abstract][Full Text] [Related]
11. Hematologic and biochemical profiles of selectively bred WHHL rabbits.
Norido F; Zatta A; Fiorito C; Prosdocimi M; Weber G
Lab Anim Sci; 1993 Aug; 43(4):319-23. PubMed ID: 8231088
[TBL] [Abstract][Full Text] [Related]
12. Cholesterol synthesis in vivo and in vitro in the WHHL rabbit, an animal with defective low density lipoprotein receptors.
Dietschy JM; Kita T; Suckling KE; Goldstein JL; Brown MS
J Lipid Res; 1983 Apr; 24(4):469-80. PubMed ID: 6304219
[TBL] [Abstract][Full Text] [Related]
13. Effects of FR145237, an acyl-CoA:cholesterol acyltransferase inhibitor, on diet-induced hypercholesterolemia in diabetic rats.
Sakuma Y; Hagihara H; Nagayoshi A; Ohne K; Mutoh S; Ito Y; Nakahara K; Notsu Y; Okuhara M
Life Sci; 1997; 60(6):351-6. PubMed ID: 9031680
[TBL] [Abstract][Full Text] [Related]
14. Natural history of atherosclerosis and hyperlipidemia in heterozygous WHHL (WHHL-Hh) rabbits. I. The effects of aging and gender on plasma lipids and lipoproteins.
Esper E; Chan EK; Buchwald H
J Lab Clin Med; 1993 Jan; 121(1):97-102. PubMed ID: 8426086
[TBL] [Abstract][Full Text] [Related]
15. Effects of pravastatin on cholesterol metabolism in Watanabe heritable hyperlipidemic rabbits.
Amorosa LF; Rozovski SJ; Ananthakrishnan R; Coly E; AlHinai A; Martucci C; Schneider SH; Shimamura T; Khachadurian AK
Jpn Heart J; 1992 Jul; 33(4):451-63. PubMed ID: 1453550
[TBL] [Abstract][Full Text] [Related]
16. Direct effect of an acyl-CoA:cholesterol acyltransferase inhibitor, F-1394, on atherosclerosis in apolipoprotein E and low density lipoprotein receptor double knockout mice.
Chiwata T; Aragane K; Fujinami K; Kojima K; Ishibashi S; Yamada N; Kusunoki J
Br J Pharmacol; 2001 Aug; 133(7):1005-12. PubMed ID: 11487509
[TBL] [Abstract][Full Text] [Related]
17. alpha-Substituted malonester amides: tools to define the relationship between ACAT inhibition and adrenal toxicity.
Sliskovic DR; Picard JA; O'Brien PM; Liao P; Roark WH; Roth BD; Anderson MA; Mueller SB; Bocan TM; Bousley RF; Hamelehle KL; Homan R; Reindel JF; Stanfield RL; Turluck D; Krause BR
J Med Chem; 1998 Feb; 41(5):682-90. PubMed ID: 9513596
[TBL] [Abstract][Full Text] [Related]
18. Impaired adrenal reserve in the Watanabe Heritable Hyperlipidemic rabbit: implications for LDL-receptor function in steroidogenesis.
Hoeg JM; Loriaux L; Gregg RE; Green WR; Brewer HB
Metabolism; 1985 Feb; 34(2):194-7. PubMed ID: 3969018
[TBL] [Abstract][Full Text] [Related]
19. Age-associated decrease in plasma cholesterol and changes in cholesterol metabolism in homozygous Watanabe heritable hyperlipidemic rabbits.
Shiomi M; Ito T; Fujioka T; Tsujita Y
Metabolism; 2000 Apr; 49(4):552-6. PubMed ID: 10778885
[TBL] [Abstract][Full Text] [Related]
20. The Watanabe heritable hyperlipidemic (WHHL) rabbit, its characteristics and history of development: a tribute to the late Dr. Yoshio Watanabe.
Shiomi M; Ito T
Atherosclerosis; 2009 Nov; 207(1):1-7. PubMed ID: 19389675
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
